|  Help  |  About  |  Contact Us

Search our database by keyword

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 2401 to 2500 out of 4141 for Mtor

0.025s

Categories

Hits by Pathway

Hits by Category

Hits by Strain

Type Details Score
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein
Organism: Mus musculus/domesticus
Length: 246  
Fragment?: false
Publication
First Author: Cullen ER
Year: 2023
Journal: J Neurosci
Title: mTORC2 Inhibition Improves Morphological Effects of PTEN Loss, But Does Not Correct Synaptic Dysfunction or Prevent Seizures.
Volume: 43
Issue: 5
Pages: 827-845
Publication
First Author: Gantois I
Year: 2017
Journal: Nat Med
Title: Metformin ameliorates core deficits in a mouse model of fragile X syndrome.
Volume: 23
Issue: 6
Pages: 674-677
Publication
First Author: Lin F
Year: 2014
Journal: Autophagy
Title: Seeing is believing: dynamic changes in renal epithelial autophagy during injury and repair.
Volume: 10
Issue: 4
Pages: 691-3
Publication
First Author: Resnick-Silverman L
Year: 2015
Journal: Cancer Discov
Title: Two Faces of SIVA.
Volume: 5
Issue: 6
Pages: 581-3
Publication
First Author: Jung SM
Year: 2019
Journal: Mol Cell
Title: Non-canonical mTORC2 Signaling Regulates Brown Adipocyte Lipid Catabolism through SIRT6-FoxO1.
Volume: 75
Issue: 4
Pages: 807-822.e8
Publication
First Author: Castro W
Year: 2018
Journal: Nat Immunol
Title: The transcription factor Rfx7 limits metabolism of NK cells and promotes their maintenance and immunity.
Volume: 19
Issue: 8
Pages: 809-820
Publication  
First Author: Huang WC
Year: 2016
Journal: Nat Commun
Title: Hyperconnectivity of prefrontal cortex to amygdala projections in a mouse model of macrocephaly/autism syndrome.
Volume: 7
Pages: 13421
Publication
First Author: Pollizzi KN
Year: 2015
Journal: J Clin Invest
Title: mTORC1 and mTORC2 selectively regulate CD8⁺ T cell differentiation.
Volume: 125
Issue: 5
Pages: 2090-108
Publication  
First Author: Gong L
Year: 2021
Journal: Cancer Lett
Title: DEPTOR inhibits lung tumorigenesis by inactivating the EGFR-mTOR signals.
Volume: 519
Pages: 263-276
Publication
First Author: Chen J
Year: 2015
Journal: J Bone Miner Res
Title: mTORC2 signaling promotes skeletal growth and bone formation in mice.
Volume: 30
Issue: 2
Pages: 369-78
Publication
First Author: Zhao X
Year: 2014
Journal: Mol Cell Biol
Title: Phosphoinositide-dependent kinase 1 and mTORC2 synergistically maintain postnatal heart growth and heart function in mice.
Volume: 34
Issue: 11
Pages: 1966-75
Publication
First Author: Andrade ML
Year: 2021
Journal: Biochim Biophys Acta Mol Cell Biol Lipids
Title: PPARγ-induced upregulation of subcutaneous fat adiponectin secretion, glyceroneogenesis and BCAA oxidation requires mTORC1 activity.
Volume: 1866
Issue: 8
Pages: 158967
Publication
First Author: Shende P
Year: 2011
Journal: Circulation
Title: Cardiac raptor ablation impairs adaptive hypertrophy, alters metabolic gene expression, and causes heart failure in mice.
Volume: 123
Issue: 10
Pages: 1073-82
Publication
First Author: Chen H
Year: 2018
Journal: Hepatology
Title: DEP domain-containing mTOR-interacting protein suppresses lipogenesis and ameliorates hepatic steatosis and acute-on-chronic liver injury in alcoholic liver disease.
Volume: 68
Issue: 2
Pages: 496-514
Protein
Organism: Mus musculus/domesticus
Length: 796  
Fragment?: true
Publication  
First Author: Angelini MM
Year: 2013
Journal: mBio
Title: Severe acute respiratory syndrome coronavirus nonstructural proteins 3, 4, and 6 induce double-membrane vesicles.
Volume: 4
Issue: 4
Publication  
First Author: Navarro G
Year: 2018
Journal: JCI Insight
Title: Androgen excess in pancreatic β cells and neurons predisposes female mice to type 2 diabetes.
Volume: 3
Issue: 12
Publication
First Author: Xu S
Year: 2021
Journal: J Bone Miner Res
Title: Rictor Is a Novel Regulator of TRAF6/TRAF3 in Osteoclasts.
Volume: 36
Issue: 10
Pages: 2053-2064
Publication
First Author: Loewith R
Year: 2002
Journal: Mol Cell
Title: Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control.
Volume: 10
Issue: 3
Pages: 457-68
Publication
First Author: Gao M
Year: 2006
Journal: Nat Cell Biol
Title: A conserved GTPase-containing complex is required for intracellular sorting of the general amino-acid permease in yeast.
Volume: 8
Issue: 7
Pages: 657-67
Publication
First Author: Dubouloz F
Year: 2005
Journal: Mol Cell
Title: The TOR and EGO protein complexes orchestrate microautophagy in yeast.
Volume: 19
Issue: 1
Pages: 15-26
Publication
First Author: Inoki K
Year: 2011
Journal: J Clin Invest
Title: mTORC1 activation in podocytes is a critical step in the development of diabetic nephropathy in mice.
Volume: 121
Issue: 6
Pages: 2181-96
Publication
First Author: Lai Y
Year: 2020
Journal: EMBO Rep
Title: DOCK5 regulates energy balance and hepatic insulin sensitivity by targeting mTORC1 signaling.
Volume: 21
Issue: 2
Pages: e49473
Publication
First Author: Zhang Y
Year: 2017
Journal: J Bone Miner Res
Title: mTORC1 Inhibits NF-κB/NFATc1 Signaling and Prevents Osteoclast Precursor Differentiation, In Vitro and In Mice.
Volume: 32
Issue: 9
Pages: 1829-1840
Publication
First Author: Wang Y
Year: 2013
Journal: Proc Natl Acad Sci U S A
Title: Tuberous sclerosis 1 (Tsc1)-dependent metabolic checkpoint controls development of dendritic cells.
Volume: 110
Issue: 50
Pages: E4894-903
Publication
First Author: Liu P
Year: 2017
Journal: Oncotarget
Title: Central role of mTORC1 downstream of YAP/TAZ in hepatoblastoma development.
Volume: 8
Issue: 43
Pages: 73433-73447
Publication
First Author: Hu S
Year: 2023
Journal: Hepatology
Title: Hepatocyte β-catenin loss is compensated by Insulin-mTORC1 activation to promote liver regeneration.
Volume: 77
Issue: 5
Pages: 1593-1611
Protein
Organism: Mus musculus/domesticus
Length: 1157  
Fragment?: false
Publication
First Author: Mieulet V
Year: 2007
Journal: Am J Physiol Cell Physiol
Title: S6 kinase inactivation impairs growth and translational target phosphorylation in muscle cells maintaining proper regulation of protein turnover.
Volume: 293
Issue: 2
Pages: C712-22
Publication
First Author: Burnett PE
Year: 1998
Journal: Proc Natl Acad Sci U S A
Title: Neurabin is a synaptic protein linking p70 S6 kinase and the neuronal cytoskeleton.
Volume: 95
Issue: 14
Pages: 8351-6
Publication
First Author: Ruvinsky I
Year: 2006
Journal: Trends Biochem Sci
Title: Ribosomal protein S6 phosphorylation: from protein synthesis to cell size.
Volume: 31
Issue: 6
Pages: 342-8
Publication
First Author: Lucchesi PA
Year: 2004
Journal: Am J Physiol Cell Physiol
Title: Rapamycin plays a new role as differentiator of vascular smooth muscle phenotype. focus on "The mTOR/p70 S6K1 pathway regulates vascular smooth muscle differentiation".
Volume: 286
Issue: 3
Pages: C480-1
Publication
First Author: Thomas G
Year: 2002
Journal: Biol Res
Title: The S6 kinase signaling pathway in the control of development and growth.
Volume: 35
Issue: 2
Pages: 305-13
Publication
First Author: Hasumi H
Year: 2008
Journal: Gene
Title: Identification and characterization of a novel folliculin-interacting protein FNIP2.
Volume: 415
Issue: 1-2
Pages: 60-7
Publication
First Author: Kus BM
Year: 2004
Journal: Proteins
Title: Functional interaction of 13 yeast SCF complexes with a set of yeast E2 enzymes in vitro.
Volume: 54
Issue: 3
Pages: 455-67
Publication
First Author: Fernández-Sáiz V
Year: 2013
Journal: Nat Cell Biol
Title: SCFFbxo9 and CK2 direct the cellular response to growth factor withdrawal via Tel2/Tti1 degradation and promote survival in multiple myeloma.
Volume: 15
Issue: 1
Pages: 72-81
Protein Domain
Type: Family
Description: This family consists of Raptor (regulatory associated protein of TOR) and its orthologs which includes Kog1p of Saccharomyces cerevisiae (Baker's yeast), a highly conserved 150kDa TOR-binding protein [, , ]. The target-of-rapamycin (TOR) proteins are protein kinases that were first identified in S. cerevisiae through mutants that conferred resistance to growth inhibition induced by the immunosuppressive macrolide rapamycin [].All Raptor orthologs contain a unique conserved region in their N-terminal half (raptor N-terminal conserved, also called the RNC domain) followed by three HEAT (huntingtin, elongation factor 3, A subunit of protein phosphatase 2A and TOR1) repeats and seven WD-40 repeats near the C terminus. Research on mammalian Raptor suggests that its association with mTOR promotes the phosphorylation of downstream effectors in nutrient-stimulated cells [, ]. In concordance with these observations, the binding of TOR to Raptor or to Kog1p []is necessary for TOR signalling in vivo in Caenorhabditis elegans and S. cerevisiae [, ].The RNC domain consists of 3 blocks with at least 67 to 79% sequence similarity and is predicted to have a high propensity to form alpha helices. The RNC domain is characterised by the presence of invariant catalytic Cys-His dyad, which is structurally and evolutionarily related to known caspases, suggesting that the raptor proteins may have protease activity [].
Protein Domain
Type: Domain
Description: This entry represents the non-structural protein 6 (NSP6) from betacoronavirus. Recently, it was reported that SARS-CoV-2 NSP6 binds TANK binding kinase 1 (TBK1) to suppress interferon regulatory factor 3 (IRF3) phosphorylation which suppresses IFN-I signalling and production more efficiently than SARS-CoV and MERS-CoV [].Coronaviruses (CoV) redirect and rearrange host cell membranes as part of the viral genome replication and transcription machinery; they induce the formation of double-membrane vesicles in infected cells. CoV non-structural protein 6 (NSP6), a transmembrane-containing protein, together with NSP3 and NSP4, have the ability to induce double-membrane vesicles that are similar to those observed in severe acute respiratory syndrome (SARS) coronavirus-infected cells []. By itself, NSP6 can generate autophagosomes from the endoplasmic reticulum. Autophagosomes are normally generated as a cellular response to starvation to carry cellular organelles and long-lived proteins to lysosomes for degradation. Degradation through autophagy may provide an innate defense against virus infection, or conversely, autophagosomes can promote infection by facilitating the assembly of replicase proteins []. In additionto initiating autophagosome formation, NSP6 also limits autophagosome expansion regardless of how they were induced, i.e. whether they were induced directly by NSP6, or indirectly by starvation or chemical inhibition of MTOR signalling. This may favour coronavirus infection by compromising the ability of autophagosomes to deliver viral components to lysosomes for degradation [].
Protein Domain
Type: Domain
Description: This entry represents the non-structural protein 6 (NSP6) from gammacoronavirus.Coronaviruses (CoV) redirect and rearrange host cell membranes as part of the viral genome replication and transcription machinery; they induce the formation of double-membrane vesicles in infected cells. CoV non-structural protein 6 (NSP6), a transmembrane-containing protein, together with NSP3 and NSP4, have the ability to induce double-membrane vesicles that are similar to those observed in severe acute respiratory syndrome (SARS) coronavirus-infected cells []. By itself, NSP6 can generate autophagosomes from the endoplasmic reticulum. Autophagosomes are normally generated as a cellular response to starvation to carry cellular organelles and long-lived proteins to lysosomes for degradation. Degradation through autophagy may provide an innate defense against virus infection, or conversely, autophagosomes can promote infection by facilitating the assembly of replicase proteins []. In addition to initiating autophagosome formation, NSP6 also limits autophagosome expansion regardless of how they were induced, i.e. whether they were induced directly by NSP6, or indirectly by starvation or chemical inhibition of MTOR signalling. This may favour coronavirus infection by compromising the ability of autophagosomes to deliver viral components to lysosomes for degradation [].
Protein Domain
Type: Domain
Description: This entry represents the non-structural protein 6 (NSP6) from alphacoronavirus.Coronaviruses (CoV) redirect and rearrange host cell membranes as part of the viral genome replication and transcription machinery; they induce the formation of double-membrane vesicles in infected cells. CoV non-structural protein 6 (NSP6), a transmembrane-containing protein, together with NSP3 and NSP4, have the ability to induce double-membrane vesicles that are similar to those observed in severe acute respiratory syndrome (SARS) coronavirus-infected cells []. By itself, NSP6 can generate autophagosomes from the endoplasmic reticulum. Autophagosomes are normally generated as a cellular response to starvation to carry cellular organelles and long-lived proteins to lysosomes for degradation. Degradation through autophagy may provide an innate defense against virus infection, or conversely, autophagosomes can promote infection by facilitating the assembly of replicase proteins []. In addition to initiating autophagosome formation, NSP6 also limits autophagosome expansion regardless of how they were induced, i.e. whether they were induced directly by NSP6, or indirectly by starvation or chemical inhibition of MTOR signalling. This may favour coronavirus infection by compromising the ability of autophagosomes to deliver viral components to lysosomes for degradation [].
Protein Domain
Type: Family
Description: This entry represents ribosomal protein S6 kinase (or p70S6K). S6 kinase is a serine/threonine kinase (STK) that catalyses the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. It contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). S6 kinase is part of the mammalian target of rapamycin (mTOR) pathway, which is a key regulator of cell growth via the regulation of protein synthesis. Both S6 kinase and eukaryotic initiation factor 4E-binding protein 1 (4EBP-1) are key mTOR effectors of cell growth [, , , ]. S6 kinase specifically phosphorylates ribosomal protein S6 in response to insulin or several classes of mitogens. S6 kinase is activated by serine/threonine phosphorylation and protein kinase C, and is inactivated by type 2A phosphatase []. S6 kinase interacts with PPP1R9A/neurabin-1 []. S6 kinase also plays a pivotal role glucose homeostasis. Its targets include the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of S6 kinase, named S6K1 and S6K2 (or S6K-beta). S6 kinase is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.
Protein Domain
Type: Family
Description: Birt-Hogg-Dube' syndrome, a disorder characterised by benign tumours of the hair follicle, lung cysts and renal neoplasia, is caused by germline mutations in the BHD(FLCN) gene; this encodes a tumour suppressor protein, folliculin (FLCN), of unknown function []. The folliculin- interacting protein, FNIP1, has also been identified and shown to interact with 5' AMP-activated protein kinase (AMPK), which plays a vital role in energy sensing []. Together, then, it is thought that folliculin (mutated in Birt-Hogg-Dube' syndrome) and its interaction partner, FNIP1, may be involved in energy and/or nutrient sensing via the AMPK and mTOR signalling pathways.FNIP1 has a homologue, FNIP2, which also interacts with FLCN and AMPK. C-terminally-deleted FLCN mutants, like those produced by germline mutations in BHD patients, do not bind FNIP2, suggesting that FLCN tumour-suppressor function may be facilitated by interactions with both FNIP1 and FNIP2 via its C terminus []. FNIP1 and FNIP2 are able to form homo- or heteromeric multimers, and may hence function either independently or cooperatively with FLCN [].This entry represents the FNIP family, including FNIP1 and FNIP2.
Publication
First Author: Liu Q
Year: 2022
Journal: Cell Death Dis
Title: IL-1β-activated mTORC2 promotes accumulation of IFN-γ+ γδ T cells by upregulating CXCR3 to restrict hepatic fibrosis.
Volume: 13
Issue: 4
Pages: 289
Publication
First Author: Zeng H
Year: 2013
Journal: Nature
Title: mTORC1 couples immune signals and metabolic programming to establish T(reg)-cell function.
Volume: 499
Issue: 7459
Pages: 485-90
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein
Organism: Mus musculus/domesticus
Length: 481  
Fragment?: false
Publication  
First Author: So EY
Year: 2013
Journal: J Cancer Biol Res
Title: The Potential Role of BRCA1-Associated ATM Activator-1 (BRAT1) in Regulation of mTOR.
Volume: 1
Issue: 1
Publication
First Author: Nardella C
Year: 2008
Journal: Genes Dev
Title: Aberrant Rheb-mediated mTORC1 activation and Pten haploinsufficiency are cooperative oncogenic events.
Volume: 22
Issue: 16
Pages: 2172-7
Publication
First Author: Obayashi Y
Year: 2013
Journal: Biochem Biophys Res Commun
Title: Impaired lipid accumulation in the liver of Tsc2-heterozygous mice during liver regeneration.
Volume: 437
Issue: 1
Pages: 146-50
Publication
First Author: Anisimov VN
Year: 2010
Journal: Am J Pathol
Title: Rapamycin extends maximal lifespan in cancer-prone mice.
Volume: 176
Issue: 5
Pages: 2092-7
Publication
First Author: Zhou X
Year: 2021
Journal: Cell Rep
Title: Stearoyl-CoA Desaturase-Mediated Monounsaturated Fatty Acid Availability Supports Humoral Immunity.
Volume: 34
Issue: 1
Pages: 108601
Publication
First Author: Chae YC
Year: 2012
Journal: Cancer Cell
Title: Control of tumor bioenergetics and survival stress signaling by mitochondrial HSP90s.
Volume: 22
Issue: 3
Pages: 331-44
Publication
First Author: Goorden SM
Year: 2011
Journal: Mol Cell Biol
Title: Rheb is essential for murine development.
Volume: 31
Issue: 8
Pages: 1672-8
Publication
First Author: Kaul A
Year: 2012
Journal: Genes Dev
Title: Pediatric glioma-associated KIAA1549:BRAF expression regulates neuroglial cell growth in a cell type-specific and mTOR-dependent manner.
Volume: 26
Issue: 23
Pages: 2561-6
Publication  
First Author: Andrade-Talavera Y
Year: 2015
Journal: Neurobiol Dis
Title: Rapamycin restores BDNF-LTP and the persistence of long-term memory in a model of Down's syndrome.
Volume: 82
Pages: 516-525
Publication
First Author: Badodi S
Year: 2021
Journal: Nat Commun
Title: Inositol treatment inhibits medulloblastoma through suppression of epigenetic-driven metabolic adaptation.
Volume: 12
Issue: 1
Pages: 2148
Publication
First Author: Li J
Year: 2014
Journal: Cell Metab
Title: Rapamycin: one drug, many effects.
Volume: 19
Issue: 3
Pages: 373-9
Publication
First Author: Witkowski S
Year: 2010
Journal: FEBS Lett
Title: High-frequency electrically stimulated skeletal muscle contractions increase p70s6k phosphorylation independent of known IGF-I sensitive signaling pathways.
Volume: 584
Issue: 13
Pages: 2891-5
Publication  
First Author: Zhang Y
Year: 2012
Journal: Elife
Title: The starvation hormone, fibroblast growth factor-21, extends lifespan in mice.
Volume: 1
Pages: e00065
Publication
First Author: Uhrbom L
Year: 2004
Journal: Nat Med
Title: Dissecting tumor maintenance requirements using bioluminescence imaging of cell proliferation in a mouse glioma model.
Volume: 10
Issue: 11
Pages: 1257-60
Publication
First Author: Hay N
Year: 2005
Journal: Cancer Cell
Title: The Akt-mTOR tango and its relevance to cancer.
Volume: 8
Issue: 3
Pages: 179-83
Publication
First Author: Bobrovnikova-Marjon E
Year: 2012
Journal: Mol Cell Biol
Title: PERK utilizes intrinsic lipid kinase activity to generate phosphatidic acid, mediate Akt activation, and promote adipocyte differentiation.
Volume: 32
Issue: 12
Pages: 2268-78
Publication
First Author: Stead RL
Year: 2013
Journal: FEBS Lett
Title: Rapamycin enhances eIF4E phosphorylation by activating MAP kinase-interacting kinase 2a (Mnk2a).
Volume: 587
Issue: 16
Pages: 2623-8
Publication
First Author: Zhang K
Year: 2022
Journal: Nat Commun
Title: mTORC1 signaling facilitates differential stem cell differentiation to shape the developing murine lung and is associated with mitochondrial capacity.
Volume: 13
Issue: 1
Pages: 7252
Publication
First Author: Wang Q
Year: 2018
Journal: Cancer Res
Title: Deptor Is a Novel Target of Wnt/β-Catenin/c-Myc and Contributes to Colorectal Cancer Cell Growth.
Volume: 78
Issue: 12
Pages: 3163-3175
Publication
First Author: Ramírez JA
Year: 2019
Journal: J Immunol
Title: Folliculin Interacting Protein 1 Maintains Metabolic Homeostasis during B Cell Development by Modulating AMPK, mTORC1, and TFE3.
Volume: 203
Issue: 11
Pages: 2899-2908
Publication
First Author: Chen J
Year: 2015
Journal: PLoS One
Title: mTORC1 Signaling Promotes Osteoblast Differentiation from Preosteoblasts.
Volume: 10
Issue: 6
Pages: e0130627
Publication
First Author: Zhao Y
Year: 2021
Journal: Gastroenterology
Title: mTORC1 and mTORC2 Converge on the Arp2/3 Complex to Promote KrasG12D-Induced Acinar-to-Ductal Metaplasia and Early Pancreatic Carcinogenesis.
Volume: 160
Issue: 5
Pages: 1755-1770.e17
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: Mus caroli
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: Mus pahari
Protein Coding Gene
Type: protein_coding_gene
Organism: Mus spretus
Publication
First Author: Caron A
Year: 2016
Journal: Am J Physiol Regul Integr Comp Physiol
Title: DEPTOR in POMC neurons affects liver metabolism but is dispensable for the regulation of energy balance.
Volume: 310
Issue: 11
Pages: R1322-31
Publication  
First Author: Ouyang Z
Year: 2022
Journal: Biomed Pharmacother
Title: DEPTOR exacerbates bone-fat imbalance in osteoporosis by transcriptionally modulating BMSC differentiation.
Volume: 151
Pages: 113164
GXD Expression    
Probe: MGI:7596429
Assay Type: Western blot
Annotation Date: 2024-02-23
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1672826
Stage: TS26
Assay Id: MGI:7596446
Age: embryonic day 18.5
Image: 7
Specimen Label: 1
Detected: true
Specimen Num: 1
GXD Expression    
Probe: MGI:7596429
Assay Type: Western blot
Annotation Date: 2024-02-23
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1672826
Stage: TS26
Assay Id: MGI:7596446
Age: embryonic day 18.5
Image: 7
Specimen Label: 2
Detected: true
Specimen Num: 2
GXD Expression    
Probe: MGI:7596429
Assay Type: Western blot
Annotation Date: 2024-02-23
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1672826
Stage: TS26
Assay Id: MGI:7596446
Age: embryonic day 18.5
Image: 7
Specimen Label: 3
Detected: true
Specimen Num: 3
GXD Expression    
Probe: MGI:7596429
Assay Type: Western blot
Annotation Date: 2024-02-23
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1672826
Stage: TS26
Assay Id: MGI:7596446
Age: embryonic day 18.5
Image: 7
Specimen Label: 4
Detected: true
Specimen Num: 4
GXD Expression    
Probe: MGI:7596429
Assay Type: Western blot
Annotation Date: 2024-02-23
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1672826
Stage: TS26
Assay Id: MGI:7596446
Age: embryonic day 18.5
Image: 7
Specimen Label: 5
Detected: true
Specimen Num: 5
GXD Expression    
Probe: MGI:7596429
Assay Type: Western blot
Annotation Date: 2024-02-23
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1672826
Stage: TS26
Assay Id: MGI:7596446
Age: embryonic day 18.5
Image: 7
Specimen Label: 6
Detected: true
Specimen Num: 6
GXD Expression    
Probe: MGI:7596429
Assay Type: Western blot
Annotation Date: 2024-02-23
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1672826
Stage: TS26
Assay Id: MGI:7596446
Age: embryonic day 18.5
Image: 7
Specimen Label: 7
Detected: true
Specimen Num: 7
GXD Expression    
Probe: MGI:7596429
Assay Type: Western blot
Annotation Date: 2024-02-23
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1672826
Stage: TS26
Assay Id: MGI:7596446
Age: embryonic day 18.5
Image: 7
Specimen Label: 8
Detected: true
Specimen Num: 8